Modaplex Platform

This proprietary platform enables the quantification of up to 2,000 DNA and RNA targets within 3.5 hours

Hemato-Oncology

Molecular diagnostics of Acute Myeloid Leukemia (AML) / Chimerism monitoring after allogenic stem cell transplantation

COVID-19 Assays

We are distributing kits for the detection of SARS-CoV-2 and other viruses. The kits are developed and owned by Primerdesign Ltd., situated in the UK.

Custom Solutions

Biotype’s contract development & manufacturing premium service covers all the challenges, right from the idea up to a marketable product

Modaplex closes diagnostic gap

We are expanding our product portfolio by offering assays and services for the Modaplex, a novel molecular diagnostic platform that bridges the gap between qPCR and Next Generation Sequencing.

Its unique combination of PCR amplification and parallel performed capillary electrophoresis enables the quantification of up to 50 DNA and/or RNA markers per sample within 3.5 hours. Explore all the additional advantages it creates for your molecular diagnostics, either for customized development, routine use, or for technology transfer.

Events

MEDICA 2021
15^th – 18^th November 2021 / Düsseldorf / Germany

Modaplex KNB Mutation Analysis Kits

We launch 3 new assays on our molecular diagnostic platform Modaplex^TM:

Modaplex KRAS Mutation Analysis Kit
Modaplex NRAS Mutation Analysis Kit
Modaplex BRAF Mutation Analysis Kit

The kits (research use only) enable the detection of 13 KRAS, 13 NRAS, and 4 BRAF (KNB) mutations together in a single run.

Latest news

#SOLVECoV2: 10 Saxony biotech solutions to fight the pandemic

28-06-2021
Biotechnology and medical technology companies based in Saxony made a significant contribution to combating the corona pandemic.